Entero Healthcare IPO: Should you subscribe? Check Anil Singhvi's View

Entero Healthcare IPO: Today is the last chance for investors to subscribe to Entero Healthcare IPO. The IPO is a combination of fresh issue of up to Rs 1,000 crore and an Offer For Sale (OFS) of up to 47,69,475 equity shares, aggregating up to Rs 600 crore at the upper end of the price band. Price range for the offer is Rs 1,195-1,258 a share.

Entero Healthcare IPO Buy or Not: Check Anil Singhvi's View

According to Zee Business Managing Editor Anil Singhvi, one should wait for the listing for more clarity and should buy shares after listing. "High-risk investors can invest for long term," he added.

Entero Healthcare IPO Preview:

Positives:

- New age start-up company

- Fastest growing healthcare distributor

- Pan-India strong presence

- Became profitable this year

Negatives:

- Negative cash flows

- Higher working capital requirement and debt

- Loss-making in the last three years

Earlier, Healthcare products distributor Entero Healthcare Solutions collected Rs 716 crore from anchor investors.

The company has allotted a total of 56.95 lakh equity shares to 25 funds at Rs 1,258 a piece, which is also the upper end of the price band, according to a circular uploaded on BSE's website late on Thursday.

The anchor book saw participation from investors, including the Capital Group, Government of Singapore, Monetary Authority of Singapore, Amundi Funds New Silk Road, Societe Generale, Morgan Stanley Asia (Singapore) Pte, Goldman Sachs (Singapore) Pte, and Copthall Mauritius Investment Ltd.

Additionally, Bajaj Allianz Life Insurance Company, SBI General Insurance, and Jupiter India Fund participated in the anchor round.
The issue, with a price band of Rs 1,195-1,258 per share, opened for public subscription on Friday. It will close on February 13.